LncRNA NEAT1在动脉粥样硬化性心血管疾病中作用机制研究进展

摘要/Abstract

摘要： 随着二代测序技术的不断发展，研究发现基因组序列转录成长链非编码RNA（LncRNA）参与心血管疾病发生发展，核内富集转录物1（nuclear enriched abundant transcript 1，NEAT1）是11号染色体转录的LncRNA，在基因表达调控中起着重要作用，广泛参与调控个体的生长发育以及细胞分化、增殖、凋亡等生命活动，广泛参与机体的生理及各种疾病的病理过程。近年来研究发现，LncRNA NEAT1参与动脉粥样硬化性心血管疾病发生发展过程。本研究主要就LncRNA NEAT1在动脉粥样硬化、冠状动脉粥样硬化性心脏病的作用机制进行综述，以期为心血管疾病的诊疗提供潜在靶点和新的诊疗思路。

关键词: font-size:medium, ">长链非编码RNA；核内富集转录物1；动脉粥样硬化；动脉粥样硬化性心血管疾病

Abstract: With the continuous development of second-generation sequencing technology， it has been found that long non-coding RNA (Lnc RNA) is involved in the occurrence and development of cardiovascular diseases. Nuclear enriched abundant transcript 1 (NEAT1) is a Lnc RNA transcribed on chromosome 11， which plays an important role in gene expression regulation and is widely involved in regulating individual growth and development， cell differentiation， proliferation， apoptosis and other life activities， and also widely involved in body physiology and pathological processes of various diseases.In recent years， studies have found that LncRNA NEAT1 is involved in the occurrence and development of atherosclerotic cardiovascular disease. This paper mainly reviews the actionmechanism of LncRNA NEAT1 in atherosclerosis and coronary heart disease， in order to provide potential targets and new ideas for the diagnosis and treatment of cardiovascular disease.

Key words: Longnon-coding RNA;Nuclear enriched abundant transcript 1, Atherosclerosis, Coronary heart disease

中图分类号:

邓云霞 , 唐湘宇, 周佩, 吴蓉, 邓豪. LncRNA NEAT1在动脉粥样硬化性心血管疾病中作用机制研究进展[J]. 中国医药导刊, 2022, 24(5): 479-483.

DENG Yunxia, TANG Xiangyu, ZHOU Pei, WU Rong, DENG Hao. Research Progress on the Mechanism of LncRNA NEAT1 in Atherosclerotic Cardiovascular Disease[J]. CHINESE JOURNAL OF MEDICINAL GUIDE, 2022, 24(5): 479-483.

参考文献

[1]Hutchinson JN，Ensminger AW，Clemson CM， et al.A screen for nuclear transcripts identifies two linked noncoding RNAs associated with SC35 splicing domains[J].BMC Genomics，2007，8:39.
     [2]Taiana E，Ronchetti D，Todoerti K， et al.LncRNA NEAT1 in paraspeckles: A structural scaffold for cellular DNA damage response systems?[J].Noncoding RNA，2020，6(3):26.
     [3]Pisani G，Baron B.Nuclear paraspeckles function in mediating gene regulatory and apoptotic pathways[J].Noncoding RNA Res，2019，4(4):128-134.
     [4]Wang Z，Li K，Huang W.Long non-coding RNA NEAT1-centric gene regulation[J].Cell Mol Life Sci，2020，77(19):3769-3779.
     [5]Klec C，Prinz F，Pichler M.Involvement of the long noncoding RNA NEAT1 in carcinogenesis[J].Mol Oncol，2019，13(1):46-60.
     [6]Yu X，Li Z，Zheng H， et al.NEAT1: A novel cancer-related long non-coding RNA[J].Cell Prolif，2017，50(2)：e12329.
     [7]Zhang M，Wu WB，Wang ZW， et al.LncRNA NEAT1 is closely related with progression of breast cancer via promoting proliferation and EMT[J].Eur Rev Med Pharmacol Sci，2017，21(5):1020-1026.
     [8]Bai J，Huang G.Role of long non-coding RNA NEAT1 in the prognosis of prostate cancer patients[J].Medicine (Baltimore)，2020，99(22):e20204.
     [9]Li S，Yang J，Xia Y， et al.Long Noncoding RNA NEAT1 promotes proliferation and invasion via targeting miR-181a-5p in non-small cell lung cancer[J].Oncol Res，2018，26(2):289-296.
     [10]夏天，肖丙秀，郭俊明.长链非编码RNA的作用机制及其研究方法[J].遗传，2013，35(3):269-280.
     [11]Wu X， Zheng X， Cheng J， et al. LncRNA TUG1 regulates proliferation and apoptosis by regulating miR-148b/IGF2 axis in ox-LDL-stimulated VSMC and HUVEC[J]. Life Sci， 2020，243:117287.
     [12]孙骏，肖亮，宋健博.长链非编码RNA NEAT1对血管平滑肌细胞增殖和凋亡的影响及作用机制[J].中国医科大学学报，2020，49(7):601-605.
     [13]周倩，李双阳，徐萍，等.NEAT1通过miR-504-5p调控主动脉粥样硬化模型细胞生物学功能[J].中国老年学杂志，2021，41(19):4367-4373.
     [14]李玉霞，商瑀家，宋佳新，等.血管平滑肌细胞表型转换与动脉粥样硬化关系的研究进展[J].医学研究杂志，2021，50(2):17-19，27.
     [15]Yang F， Chen Q， He S， et al. miR-22 Is a novel mediator of vascular smooth mMuscle cell phenotypic modulation and neointima formation[J]. Circulation， 2018，137(17):1824-1841.
     [16]Zhou X， Wang X， Zhou Y， et al. Long non-coding RNA NEAT1 promotes cell proliferation and invasion and suppresses apoptosis in hepatocellular carcinoma by regulating miRNA-22-3p/akt2 in vitro and in vivo[J]. Onco Targets Ther， 2019，12:8991-9004.
     [17]Kim YM，Choi BM，Kim YS， et al.Protective effect of p53 in vascular smooth muscle cells against nitric oxide-induced apoptosis is mediated by up-regulation of heme oxygenase-2[J].BMB Rep，2008，41(2):164-169.
     [18]Kenneweg F，Bang C，Xiao K， et al.Long noncoding RNA-enriched vesicles secreted by hypoxic cardiomyocytes drive cardiac fibrosis[J].Mol Ther Nucleic Acids，2019，18:363-374.
     [19]Cooper DR，Carter G，Li P， et al.Long non-coding RNA NEAT1 associates with SRp40 to temporally regulate PPARγ2 splicing during adipogenesis in 3T3-L1 Cells[J].Genes (Basel)，2014，5(4):1050-1063.
     [20]Zhang X，Guan MX，Jiang QH， et al.NEAT1 knockdown suppresses endothelial cell proliferation and induces apoptosis by regulating miR?638/AKT/mTOR signaling in atherosclerosis[J].Oncol Rep，2020，44(1):115-125.
     [21]Huang-Fu N，Cheng JS，Wang Y， et al.Neat1 regulates oxidized low-density lipoprotein-induced inflammation and lipid uptake in macrophages via paraspeckle formation[J].Mol Med Rep，2018，17(2):3092-3098.
     [22]Wang L， Xia JW， Ke ZP， et al. Blockade of NEAT1 represses inflammation response and lipid uptake via modulating miR-342-3p in human macrophages THP-1 cells[J]. J Cell Physiol， 2019， 234(4): 5319-5326.
     [23]Chen X， Tan XR， Li SJ， et al. LncRNA NEAT1 promotes hepatic lipid accumulation via regulating miR-146a-5p/ROCK1 in nonalcoholic fatty liver disease[J]. Life Sci， 2019，235:116829.
     [24]张鹏飞. 长非编码RNA Neat1促进炎症小体激活的机制研究[D] :中国科学技术大学，2019.
     [25]Zhang M，Zheng Y，Sun Y， et al.Knockdown of NEAT1 induces tolerogenic phenotype in dendritic cells by inhibiting activation of NLRP3 inflammasome[J].Theranostics，2019，9(12):3425-3442.
     [26]Chen DD， Hui LL， Zhang XC， et al. NEAT1 contributes to ox-LDL-induced inflammation and oxidative stress in macrophages through inhibiting miR-128[J]. J Cell Biochem， 2019，120(2);2493-2501
     [27]Wang SM， Liu GQ， Xian HB， et al. LncRNA NEAT1 alleviates sepsis-induced myocardial injury by regulating the TLR2/NF-κB signaling pathway[J]. Eur Rev Med Pharmacol Sci， 2019，23(11):4898-4907.
     [28]Bitarafan S，Yari M，Broumand MA， et al.Association of increased levels of lncRNA H19 in PBMCs with risk of coronary artery disease[J].Cell J，2019，20(4):564-568.
     [29]Zhu Q，Zhao C，Wang Y， et al.LncRNA NEAT1 promote inflammatory responses in coronary slow flow through regulating miR-148b-3p/ICAM-1 axis[J].J Inflamm Res，2021，14:2445-2463.
     [30]Chen Z， Yan Y， Wu J， et al. Expression level and diagnostic value of exosomal NEAT1/miR-204/MMP-9 in acute ST-segment elevation myocardial infarction[J]. IUBMB Life，2020， 72(11): 2499-2507.
     [31]Liu H， Yan X， Yu J. Long noncoding RNA NEAT1/microRNA-125a axis predicts increased major adverse cardiac and cerebrovascular event risk independently in patients with unprotected left main coronary artery disease underwent coronary artery bypass grafting[J]. J Clin Lab Anal， 2020，34(7):e23299.
     [32]Zhu ZF，Meng K，Zhong YC， et al.Impaired circulating CD4+ LAP+ regulatory T cells in patients with acute coronary syndrome and its mechanistic study[J].PLoS One，2014，9(2):e88775.
     [33]Imamura K，Imamachi N，Akizuki G， et al.Long non-coding RNA NEAT1-dependent SFPQ relocation from promoter region to paraspeckle mediates IL8 expression upon immune stimuli[J].Mol Cell，2014，53(3):393-406.
     [34]Gast M，Rauch BH，Haghikia A， et al.Long noncoding RNA NEAT1 modulates immune cell functions and is suppressed in early onset myocardial infarction patients[J].Cardiovasc Res，2019，115(13):1886-1906.
     [35]Ma M，Hui J，Zhang QY， et al.Long non-coding RNA nuclear-enriched abundant transcript 1 inhibition blunts myocardial ischemia reperfusion injury via autophagic flux arrest and apoptosis in streptozotocin-induced diabetic rats[J].Atherosclerosis，2018，277:113-122.
     [36]Wu HJ，Tang GM，Shao PY， et al.Long non-coding RNA NEAT1 modulates hypoxia/reoxygenation-induced cardiomyocyte injury via targeting microRNA-520a[J].Exp Ther Med，2019，18(3):2199-2206.
     [37]Du XJ， Wei J， Tian D， et al. NEAT1 promotes myocardial ischemia-reperfusion injury via activating the MAPK signaling pathway[J]. J Cell Physiol， 2019，234(10):18773-18780.
     [38]Kumphune S， Surinkaew S， Chattipakorn SC， et al. Inhibition of p38 MAPK activation protects cardiac mitochondria from ischemia/reperfusion injury[J]. Pharm Biol， 2015， 53(12): 1831-1841.
     [39]Zhang M，Wang X，Yao J， et al.Long non-coding RNA NEAT1 inhibits oxidative stress-induced vascular endothelial cell injury by activating the miR-181d-5p/CDKN3 axis[J].Artif Cells Nanomed Biotechnol，2019，47(1):3129-3137.
     [40]Zhang H， Ji N， Gong X， et al. NEAT1/miR-140-3p/MAPK1 mediates the viability and survival of coronary endothelial cells and affects coronary atherosclerotic heart disease[J]. Acta Biochim Biophys Sin (Shanghai)， 2020，52(9): 967-974.
     [41]Gidl?f O， Bader K， Celik S， et al. Inhibition of the long non-coding RNA NEAT1 protects cardiomyocytes from hypoxia in vitro via decreased pri-miRNA processing[J]. Cell Death Dis， 2020，11(8):677.

快速检索引用检索图表检索高级检索